KIDNEY FUNCTION IN PAH
• Pulmonary arterial hypertension (PAH) is characterized by inflammation and vascular remodeling in the lung as well as impaired mitochondrial function in multiple organs [4] [5] [6] [7] • CKD complicates management of right heart failure in PAH 8 • Kidney dysfunction is a powerful poor prognostic factor in PAH especially in those with scleroderma [8] [9] [10] LARIAT • Consistent with previous studies of bardoxolone methyl in patients with chronic kidney disease, bardoxolone methyl significantly increased eGFR in patients with PAH
• The increase in eGFR with bardoxolone methyl was sustained through two years of treatment 
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